An interventional study of Diet and Exercise in Gestational Diabetes, sponsored by Istanbul Medipol University Hospital. Status unknown at 1 site in Turkey. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-31.
Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment
Gestational diabetes (GDM) is defined as 'pregnancy-onset or first noticed glucose intolerance'. The aim of this study is to investigate the effect of circuit exercise program applied in addition to diet therapy on cognitive function, functional exercise capacity, mobility, depression and quality of life in women with gestational diabetes. 60 female participants between the ages of 18-35 who meet the inclusion criteria will be included in the study. Participants will be randomly divided into 2 groups as diet group (n=30) and exercise group (n=30). All participants will receive GDM-specific dietary therapy for 6 weeks. In addition to diet therapy, individuals in the exercise group will be given a circuit exercise program for 6 weeks. Participants will be evaluated for blood values, cognitive status and functionality at the baseline and 6 weeks later.
842 studies on the registry are indexed under Diabetes, Gestational; 198 are open to participants now.
This study's planned enrollment of 60 is below the median of 110 across 550 interventional studies indexed under Diabetes, Gestational.
Browse Diabetes, Gestational studies →Istanbul Medipol University Hospital is the lead sponsor of 350 studies on the registry; 58 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Individuals will receive only dietary treatment that the dietitian deems appropriate for 6 weeks.
Other: Diet
In addition to the 6-week diet program that the dietitian deems appropriate, a circuit exercise program will be applied for 6 weeks. The circuit exercise program will consist of a medium-intensity circuit training for 50 minutes, 3 days a week, detailing the main muscle groups of the patients (chest, back, biceps, triceps, deltoid, quadriceps, thigh and calf muscles). Exercise intensity will be monitored using Borg's scale of perceived exertion, with a target intensity of 12 to 14. 8 exercises will be given in a continuous, circuit-type manner with short 1-minute rests.
Other: Diet · Other: Exercise
Special diet program for gestational diabetes
The circuit exercise program will consist of a medium-intensity circuit training for 50 minutes, 3 days a week, detailing the main muscle groups of the patients (chest, back, biceps, triceps, deltoid, quadriceps, thigh and calf muscles). Exercise intensity will be monitored using Borg's scale of perceived exertion, with a target intensity of 12 to 14. 8 exercises will be given in a continuous, circuit-type manner with short 1-minute rests.
Blood count test 1
Fasting blood glucose (FBG) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 2
Postprandial blood glucose (PBG) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 3
HbA1c value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 4
Total cholesterol (T-col) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 5
High-density lipoprotein cholesterol (HDL) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 6
Low-density lipoprotein cholesterol (LDL) value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 7
Insulin value will be recorded.
Time frame: 6 weeks after baseline
Blood count test 8
Triglyceride (TG) value will be recorded.
Time frame: 6 weeks after baseline
Montreal Cognitive Assessment Scale
It is a screening scale developed to evaluate the early stages of cognitive impairment. Min score is 0, max score is 30. High scores mean a better outcome.
Time frame: 6 weeks after baseline
WMS Number Range Test
In the forward number range, the patient is asked to repeat the numbers told to her in the same order, and in the backward number range, the patient is asked to repeat the said numbers from the end to the beginning. High scores mean a better outcome.
Time frame: 6 weeks after baseline
This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medipol University Hospital